# A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification

> **NCT02481258** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 35 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DRUG:** Ataciguat (HMR1766)
- **OTHER:** Placebo Comparator: Matching Placebo

## Key facts

- **NCT ID:** NCT02481258
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-07-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-01-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481258, "A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02481258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*